Corcept Therapeutics, Inc. (CORT)
121.19
+2.65
(+2.24%)
USD |
NASDAQ |
Oct 09, 16:00
120.94
-0.25
(-0.21%)
After-Hours: 20:00
Corcept Therapeutics Price : 121.19 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 118.00 | 122.34 | 117.41 | 121.19 | 624209.0 |
| Oct 08, 2026 | 118.56 | 119.16 | 115.80 | 118.54 | 496666.0 |
| Oct 07, 2026 | 119.00 | 122.00 | 117.23 | 119.60 | 634876.0 |
| Oct 06, 2026 | 122.20 | 122.54 | 115.11 | 119.57 | 790536.0 |
| Oct 05, 2026 | 115.59 | 122.81 | 115.50 | 122.03 | 1.005M |
| Oct 02, 2026 | 114.38 | 117.32 | 113.90 | 116.23 | 960162.0 |
| Oct 01, 2026 | 114.29 | 115.98 | 111.94 | 114.02 | 878988.0 |
| Sep 30, 2026 | 114.80 | 118.07 | 113.98 | 115.23 | 910311.0 |
| Sep 29, 2026 | 115.92 | 120.51 | 113.16 | 114.74 | 964470.0 |
| Sep 28, 2026 | 116.00 | 117.07 | 114.36 | 115.63 | 1.155M |
| Sep 25, 2026 | 119.00 | 120.44 | 114.51 | 116.10 | 800797.0 |
| Sep 24, 2026 | 111.86 | 119.15 | 111.68 | 118.51 | 983632.0 |
| Sep 23, 2026 | 117.33 | 118.79 | 112.04 | 112.94 | 809874.0 |
| Sep 22, 2026 | 113.96 | 119.00 | 113.09 | 117.50 | 810250.0 |
| Sep 21, 2026 | 110.29 | 116.65 | 109.00 | 113.76 | 1.347M |
| Sep 18, 2026 | 116.80 | 117.90 | 108.41 | 110.29 | 17.23M |
| Sep 17, 2026 | 113.18 | 115.09 | 111.07 | 114.86 | 883644.0 |
| Sep 16, 2026 | 110.82 | 113.60 | 110.49 | 111.81 | 668643.0 |
| Sep 15, 2026 | 111.97 | 112.80 | 109.40 | 110.82 | 1.459M |
| Sep 14, 2026 | 113.38 | 114.52 | 111.10 | 111.80 | 1.231M |
| Sep 11, 2026 | 115.22 | 117.84 | 109.30 | 112.79 | 1.282M |
| Sep 10, 2026 | 114.42 | 116.99 | 113.20 | 114.92 | 683008.0 |
| Sep 09, 2026 | 114.20 | 117.50 | 113.77 | 115.70 | 572049.0 |
| Sep 08, 2026 | 108.87 | 115.28 | 108.25 | 113.98 | 1.046M |
| Sep 04, 2026 | 110.59 | 112.13 | 109.26 | 111.62 | 604557.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1179.27 |
| Pfizer Inc. | 28.28 |
| Illumina, Inc. | 278.17 |
| Aclaris Therapeutics, Inc. | 3.83 |
| Bristol Myers Squibb Co. | 59.12 |
Price Related Metrics
| PE Ratio | 289.44 |
| PS Ratio | 16.85 |
| Price to Book Value | 18.53 |
| Price to Free Cash Flow | 130.95 |
| Earnings Yield | 0.35% |
| Market Cap | 13.08B |
| Operating PE Ratio | 2185.93 |
| Normalized PE Ratio | 289.44 |